TNF Tolerance in Monocytes and Macrophages: Characteristics and Molecular Mechanisms

被引:26
作者
Huber, Rene [1 ]
Bikker, Rolf [1 ]
Welz, Bastian [1 ]
Christmann, Martin [1 ]
Brand, Korbinian [1 ]
机构
[1] Hannover Med Sch, Inst Clin Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany
关键词
TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; EDITING ENZYME A20; E3 LIGASE ITCH; FACTOR-ALPHA; C/EBP-BETA; CROSS-TOLERANCE; SIGNALING PATHWAYS; INFLAMMATION; CELLS;
D O I
10.1155/2017/9570129
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor necrosis factor (TNF) tolerance in monocytes and macrophages means that preexposure to TNF reduces the sensitivity in these cells to a subsequent restimulation with this cytokine. Differential effects arise following preincubation with both low and high doses of TNF resulting in absolute as well as induction tolerance affecting specific immunologically relevant gene sets. In this review article, we summarize the relevance of TNF tolerance in vivo and the molecular mechanisms underlying these forms of tolerance including the role of transcription factors and signaling systems. In addition, the characteristics of cross-tolerance between TNF and lipopolysaccharide (LPS) as well as pathophysiological aspects of TNF tolerance are discussed. We conclude that TNF tolerance may represent a protective mechanism involved in the termination of inflammation and preventing excessive or prolonged inflammation. Otherwise, tolerance may also be a trigger of immune paralysis thus contributing to severe inflammatory diseases such as sepsis. An improved understanding of TNF tolerance will presumably facilitate the implementation of diagnostic or therapeutic approaches to more precisely assess and treat inflammation-related diseases.
引用
收藏
页数:9
相关论文
共 65 条
  • [1] The E3 ligase Itch in immune regulation and beyond
    Aki, Daisuke
    Zhang, Wen
    Liu, Yun-Cai
    [J]. IMMUNOLOGICAL REVIEWS, 2015, 266 (01) : 6 - 26
  • [2] TREATMENT WITH RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA PROTECTS RATS AGAINST THE LETHALITY, HYPOTENSION, AND HYPOTHERMIA OF GRAM-NEGATIVE SEPSIS
    ALEXANDER, HR
    SHEPPARD, BC
    JENSEN, JC
    LANGSTEIN, HN
    BURESH, CM
    VENZON, D
    WALKER, EC
    FRAKER, DL
    STOVROFF, MC
    NORTON, JA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) : 34 - 39
  • [3] DIFFERENTIATION FACTOR LEUKEMIA INHIBITORY FACTOR PROTECTION AGAINST LETHAL ENDOTOXEMIA IN MICE - SYNERGISTIC EFFECT WITH INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR
    ALEXANDER, HR
    WONG, GGH
    DOHERTY, GM
    VENZON, DJ
    FRAKER, DL
    NORTON, JA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) : 1139 - 1142
  • [4] Tumour necrosis factor and cancer
    Balkwill, Frances
    [J]. NATURE REVIEWS CANCER, 2009, 9 (05) : 361 - 371
  • [5] TNF phase III signalling in tolerant cells is tightly controlled by A20 and CYLD
    Bikker, Rolf
    Christmann, Martin
    Preuss, Katharina
    Welz, Bastian
    Friesenhagen, Judith
    Dittrich-Breiholz, Oliver
    Huber, Rene
    Brand, Korbinian
    [J]. CELLULAR SIGNALLING, 2017, 37 : 123 - 135
  • [6] Regulation of tumour necrosis factor signalling: live or let die
    Brenner, Dirk
    Blaser, Heiko
    Mak, Tak W.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2015, 15 (06) : 362 - 374
  • [7] The resolution of inflammation
    Buckley, Christopher D.
    Gilroy, Derek W.
    Serhan, Charles N.
    Stockinger, Brigitta
    Tak, Paul P.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2013, 13 (01) : 59 - 66
  • [8] Phosphorylation of serine 468 by GSK-3β negatively regulates basal p65 NF-κB activity
    Buss, H
    Dörrie, A
    Schmitz, ML
    Frank, R
    Livingstone, M
    Resch, K
    Kracht, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) : 49571 - 49574
  • [9] ROLES OF TUMOR NECROSIS FACTOR IN THE ILLNESS AND PATHOLOGY OF MALARIA
    CLARK, IA
    CHAUDHRI, G
    COWDEN, WB
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1989, 83 (04) : 436 - 440
  • [10] Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses
    Deiters, U
    Gumenscheimer, M
    Galanos, C
    Mühlradt, PF
    [J]. INFECTION AND IMMUNITY, 2003, 71 (08) : 4456 - 4462